“ER, PR & HER2 Receptor status in recurrent breast cancer: Its relation to age & time of recurrence”, J. Surg. Sci., vol. 22, no. 1, pp. 16–20, Mar. 2020, doi: 10.3329/jss.v22i1.44009.